Opportunity Information: Apply for CDC RFA GH13 1343
Apply for CDC RFA GH13 1343
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Strengthen Brazils National Response to HIV and other diseases through innovative and evidence based approaches in laboratory, strategic information, prevention and care activities and foster partnerships between Brazil, Angola and Mozambique (PEPFAR" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Apr 10, 2013 and posted on Jan 17, 2013.
- Applicants must submit their applications by Apr 12, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $6,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $3,500,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Assistance will be provided only to Brazil s National Department of STD, HIV/AIDS and Viral Hepatitis (NAD) through Fundao para o Desenvolvimento Tecnolgico e Cientfico em Sade (FIOTEC). No other applications are solicited. FIOTEC is the only appropriate and qualified organization to fulfill the requirements set forth for Brazil in this announcement because 1. There is no legal mechanism established for the USG to award funds directly to a Brazilian Ministry. 2. Fundao Oswaldo Cruz (FIOCRUZ) is part of the structure of the Brazilian Ministry of Health and it is the arm of the Brazilian Ministry of Health (MoH) for technical provision of capacity building in Public Health, as demonstrated in the attached Organizational Chart. It encompasses institutions like the National School of Public Health, the National Institute of Quality Control, the production of vaccines, laboratory kits and ARV drugs, among others. 3. FIOTEC is the foundation that receives and manages funds for projects developed by FIOCRUZ, as required by Agreement No 18/2008 of the Brazilian Federal Government and the FIOTEC Statute, attached. 4. FIOCRUZ/FIOTEC provide services to the MoH to coordinate and implement health sector activities, including some of those necessary for the control of the HIV/AIDS epidemic in Brazil. 5. The purpose of the announcement is to build upon an existing framework of activities for which FIOCRUZ/FIOTEC, in conjunction with the NAD, have the responsibility for implementing. 6. FIOCRUZ/FIOTEC are uniquely positioned, in terms of experience and credibility among Brazilian citizens, to provide health sector HIV/AIDS/STD Strategic Information, Laboratory Strengthening, and Treatment and Care. 7. Over the past ten years, FIOCRUZ/FIOTEC have demonstrated their skill and expertise as a partner to CDC/NAD activities through accomplishment of the following strengthening NAD and decentralizing HIV monitoring and evaluation (ME) to key locations in Brazil development of a harmonized set of structural, programatic and impact indicators publicly available at an internet based system to monitor the epidemics (MONITORAIDS) training more than 8,000 Brazilian health professionals in a 2 day ME course and more than 50 nationals in a two year Master Degree curricula in ME validating HIV rapid test diagnostic and successfully adapting and implementing three different models of evidence based behavioral interventions to HIV prevention among men who have sex with men (MSM) the most affected population in Brazil.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity (CDC RFA GH13-1343) is a CDC-funded PEPFAR cooperative agreement designed to strengthen Brazils national response to HIV while also supporting work on other diseases through innovative, evidence-based public health approaches. The core intent is to help Brazil reduce new HIV infections, improve quality of life for people living with HIV/AIDS, and lower AIDS-related mortality. At the same time, it places strong emphasis on building and sustaining universal access to health care in Brazil by improving the quality, reach, and effectiveness of systems that support prevention, diagnosis, treatment, and long-term care. A major cross-cutting objective is to substantially strengthen strategic information capacity, meaning better collection, analysis, and use of data for planning programs, tracking outcomes, and targeting resources where they will have the greatest impact.
The program is framed around practical improvements in several technical areas, particularly laboratory systems, strategic information, prevention, and care and treatment activities. Laboratory strengthening typically implies improving diagnostic and monitoring capacity, such as expanding and standardizing testing, improving quality assurance, and ensuring accurate, timely results that can guide clinical decisions and public health actions. Strategic information work is aimed at strengthening monitoring and evaluation, surveillance, and indicator systems so the national program can more reliably measure the epidemic, evaluate interventions, and make evidence-based decisions. Prevention activities focus on implementing and scaling interventions that have demonstrated effectiveness, and the FOA highlights the importance of reaching populations most affected by HIV in Brazil. Treatment and care components are geared toward improving service quality and continuity of care, which directly supports reductions in mortality and improvements in long-term health outcomes for PLWHA.
An important distinguishing feature of this opportunity is its explicit goal of fostering partnerships between Brazil and Lusophone African countries supported by PEPFAR, specifically Angola and Mozambique. In practice, this signals an intent to leverage Brazils technical expertise, experience, and public health infrastructure to support south-to-south cooperation, knowledge exchange, and capacity building. Rather than being limited to domestic Brazilian impact, the program is meant to enhance regional and language-linked collaboration, allowing approaches, tools, and training capacity developed in Brazil to inform and strengthen efforts in Angola and Mozambique as well.
From an administrative standpoint, this is a discretionary funding opportunity using a cooperative agreement mechanism, which generally means CDC expects to have substantial involvement in the project beyond standard grant oversight, such as collaboration on technical direction, work planning, and performance monitoring. The posting date was January 17, 2013, with an original closing date of April 10, 2013, later reflected as April 12, 2013, and the opportunity was archived May 10, 2013. The estimated total funding was $6.5 million, with an award ceiling of $3.5 million and no stated award floor. Only one award was expected. There was no cost sharing or matching requirement. The CFDA number associated with this opportunity is 93.067 (Global AIDS).
Eligibility is highly restricted and effectively sole-sourced. Assistance was to be provided only to Brazils National Department of STD, HIV/AIDS and Viral Hepatitis (NAD) through Fundacao para o Desenvolvimento Tecnologico e Cientifico em Saude (FIOTEC). No other applications were solicited. The justification given is that there is no legal mechanism for the US government to award funds directly to a Brazilian ministry, and FIOTEC serves as the entity that receives and manages funds for projects developed by Fundacao Oswaldo Cruz (FIOCRUZ), which is part of Brazils Ministry of Health structure and functions as a major technical arm for public health capacity building. The announcement describes FIOCRUZ as encompassing key institutions and capabilities, including training and public health education, quality control, and even production capacity for vaccines, laboratory kits, and antiretroviral drugs, which positions it as a central national resource for implementing complex health programs. FIOTEC is presented as the appropriate fiduciary and administrative mechanism for channeling and managing the cooperative agreement funds in alignment with Brazilian federal requirements and existing agreements.
The FOA also points to an established track record that underpins why FIOCRUZ/FIOTEC, working with NAD, are considered uniquely positioned to execute the work. Examples cited include strengthening NAD and decentralizing HIV monitoring and evaluation to key locations in Brazil, developing a harmonized set of indicators and making them publicly available through an internet-based system to monitor the epidemic (MONITORAIDS), and delivering large-scale training in monitoring and evaluation (more than 8,000 health professionals trained in a short course and more than 50 nationals trained through a two-year masters-level curriculum in M&E). It also references validation of HIV rapid tests and the successful adaptation and implementation of multiple models of evidence-based behavioral interventions for HIV prevention among men who have sex with men, identified in the announcement as the most affected population in Brazil. Taken together, these examples signal that the cooperative agreement was intended not as a brand-new initiative but as an expansion and reinforcement of an existing framework of activities already being implemented with demonstrated capacity and credibility.
The sponsoring agency is the Centers for Disease Control and Prevention. For access issues related to the full announcement, the listed point of contact was the CDC Procurement and Grants Office Technical Information Management, reachable by phone at (770) 488-2700 or by email at pgotim@cdc.gov.
Frequently Asked Questions (FAQs) - CDC RFA GH13-1343 (Brazil HIV/PEPFAR Cooperative Agreement)
What is CDC RFA GH13-1343?
CDC RFA GH13-1343 is a CDC-funded PEPFAR cooperative agreement focused on strengthening Brazil's national response to HIV. The opportunity emphasizes innovative, evidence-based public health approaches, while also supporting work that can benefit other diseases through stronger health systems.
What are the main goals of this cooperative agreement?
The core intent is to help Brazil reduce new HIV infections, improve quality of life for people living with HIV/AIDS (PLWHA), and reduce AIDS-related mortality. It also emphasizes building and sustaining universal access to health care in Brazil by improving the quality, reach, and effectiveness of prevention, diagnosis, treatment, and long-term care systems.
What does "strategic information capacity" mean in this funding opportunity?
Strategic information capacity refers to improving how data are collected, analyzed, and used for planning programs, tracking outcomes, and targeting resources where they can have the greatest impact. This includes strengthening monitoring and evaluation, surveillance, and indicator systems so the national program can more reliably measure the epidemic and evaluate interventions.
Which technical areas are emphasized by the program?
The program is framed around practical improvements in several technical areas, particularly laboratory systems, strategic information, prevention, and care and treatment activities.
What kinds of activities are included under laboratory strengthening?
Laboratory strengthening typically implies improving diagnostic and monitoring capacity. Examples described include expanding and standardizing testing, improving quality assurance, and ensuring accurate, timely results that guide clinical decisions and public health actions.
What types of prevention activities are highlighted?
Prevention activities focus on implementing and scaling interventions that have demonstrated effectiveness. The announcement highlights the importance of reaching populations most affected by HIV in Brazil, including men who have sex with men (identified in the announcement as the most affected population in Brazil).
What does the opportunity say about care and treatment activities?
Treatment and care components are geared toward improving service quality and continuity of care, supporting reductions in mortality and improvements in long-term health outcomes for PLWHA.
Does this opportunity include international partnership or collaboration components?
Yes. A distinguishing feature is the explicit goal of fostering partnerships between Brazil and Lusophone African countries supported by PEPFAR, specifically Angola and Mozambique. The intent is to leverage Brazil's technical expertise and public health infrastructure for south-to-south cooperation, knowledge exchange, and capacity building.
What is the funding mechanism for this opportunity?
This is a discretionary funding opportunity using a cooperative agreement mechanism. This generally means CDC expects substantial involvement beyond standard grant oversight, such as collaborating on technical direction, work planning, and performance monitoring.
When was the opportunity posted and when did it close?
The posting date was January 17, 2013. The original closing date was April 10, 2013, later reflected as April 12, 2013. The opportunity was archived on May 10, 2013.
How much funding was available under CDC RFA GH13-1343?
The estimated total funding was $6.5 million. The award ceiling was $3.5 million, and there was no stated award floor. Only one award was expected.
Was cost sharing or matching required?
No. The funding opportunity states there was no cost sharing or matching requirement.
How many awards were expected to be made?
Only one award was expected.
What is the CFDA number for this opportunity?
The CFDA number associated with this opportunity is 93.067 (Global AIDS).
Who was eligible to apply?
Eligibility was highly restricted and effectively sole-sourced. Assistance was to be provided only to Brazil's National Department of STD, HIV/AIDS and Viral Hepatitis (NAD) through Fundacao para o Desenvolvimento Tecnologico e Cientifico em Saude (FIOTEC). No other applications were solicited.
Why was eligibility restricted to NAD through FIOTEC?
The justification provided is that there is no legal mechanism for the U.S. government to award funds directly to a Brazilian ministry, and FIOTEC serves as the entity that receives and manages funds for projects developed by Fundacao Oswaldo Cruz (FIOCRUZ), which is part of Brazil's Ministry of Health structure and serves as a major technical arm for public health capacity building.
What role does FIOCRUZ play in this opportunity?
FIOCRUZ is described as a central national resource for implementing complex health programs, encompassing capabilities such as training and public health education, quality control, and production capacity for vaccines, laboratory kits, and antiretroviral drugs.
What role does FIOTEC play in this opportunity?
FIOTEC is presented as the appropriate fiduciary and administrative mechanism to receive and manage cooperative agreement funds for projects developed by FIOCRUZ, aligning grant management with Brazilian federal requirements and existing agreements.
What examples of past performance or experience are cited to support the selected implementers?
The announcement cites examples including: strengthening NAD and decentralizing HIV monitoring and evaluation to key locations in Brazil; developing a harmonized set of indicators made publicly available through an internet-based system (MONITORAIDS); delivering large-scale training in monitoring and evaluation (more than 8,000 health professionals trained in a short course and more than 50 nationals trained through a two-year masters-level curriculum in M&E); validation of HIV rapid tests; and adapting and implementing evidence-based behavioral interventions for HIV prevention among men who have sex with men.
Is this opportunity described as a new initiative or an expansion of existing work?
The cited history and examples indicate the cooperative agreement was intended as an expansion and reinforcement of an existing framework of activities with demonstrated capacity and credibility, rather than a brand-new initiative.
Which U.S. agency sponsored this funding opportunity?
The sponsoring agency is the Centers for Disease Control and Prevention (CDC).
Who was the listed contact for access issues related to the full announcement?
The listed point of contact was the CDC Procurement and Grants Office Technical Information Management. The contact phone number provided was (770) 488-2700 and the email provided was pgotim@cdc.gov.
Browse more opportunities from the same category: Health
Next opportunity: Tanzanian Ministry of Health and Social Welfare System Strengthening for Enhanced Evidence Based Decision Making and Management and Delivery of Quality Health Services in the United Republic of Tanzania under the Presidents Emergency Plan for AIDS Re
Previous opportunity: 2013 Marine Education and Training Mini Grant Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH13 1343
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH13 1343) also looked into and applied for these:
| Funding Opportunity |
|---|
| Tanzanian Ministry of Health and Social Welfare System Strengthening for Enhanced Evidence Based Decision Making and Management and Delivery of Quality Health Services in the United Republic of Tanzania under the Presidents Emergency Plan for AIDS Re Apply for CDC RFA GH13 1319 Funding Number: CDC RFA GH13 1319 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Rural Training Track Technical Assistance Demonstration Program Apply for HRSA 13 247 Funding Number: HRSA 13 247 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Modification 1 Questions and Answer to the APS Apply for APS 442 13 000001 Funding Number: APS 442 13 000001 Agency: Cambodia USAID Phnom Penh Category: Health Funding Amount: $100,000 |
| Drug Free Communities (DFC) Support Program Apply for SP 13 002 Funding Number: SP 13 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $125,000 |
| Support for Community Vital Registration in the Republic of Zambia under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1349 Funding Number: CDC RFA GH13 1349 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| HIV care and treatment services in the Dukwi refugee camp in Botswana under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1355 Funding Number: CDC RFA GH13 1355 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| The Namibian Mechanism for Public Health and Medical Education (NAM PHAME) under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1358 Funding Number: CDC RFA GH13 1358 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,200,000 |
| Improving the Quality of Namibias Essential Health Apply for CDC RFA GH13 1359 Funding Number: CDC RFA GH13 1359 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $23,000,000 |
| Delta States Rural Development Network Grant Program Apply for HRSA 13 157 Funding Number: HRSA 13 157 Agency: Health Resources and Services Administration Category: Health Funding Amount: $25,000 |
| Capacity Strengthening to Support Provision of High Quality and Evidence based HIV Prevention, Care and Treatment Services to Staff and Family Members of the Kenya Disciplined Services Community (Kenya Police, Administration Police, Kenya Wildlife Se Apply for CDC RFA GH13 1307 Funding Number: CDC RFA GH13 1307 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| Core Centers for Musculoskeletal Biology and Medicine (P30) Apply for RFA AR 14 002 Funding Number: RFA AR 14 002 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Skin Diseases Research Core Centers (P30) Apply for RFA AR 14 001 Funding Number: RFA AR 14 001 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Culturally Appropriate Interventions of Outreach, Access and Retention among Latino/a Populations Evaluation and Technical Assistance Center Apply for HRSA 13 151 Funding Number: HRSA 13 151 Agency: Health Resources and Services Administration Category: Health Funding Amount: $550,000 |
| Culturally Appropriate Interventions of Outreach, Access and Retention among Latino/a Populations Demonstration Sites Apply for HRSA 13 154 Funding Number: HRSA 13 154 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Strengthening National Health Laboratory Services in Uganda under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1333 Funding Number: CDC RFA GH13 1333 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| FY 2013 Targeted Capacity Expansion Peer to Peer Apply for TI 13 001 Funding Number: TI 13 001 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $250,000 |
| Technical Assistance Services to Countries Supported by the Presidents Emergency Plan for HIV/AIDS Relief (PEPFAR) and the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria Apply for CDC RFA GH13 1368 Funding Number: CDC RFA GH13 1368 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $15,000,000 |
| Modification no. 2 Apply for APS 442 13 000001 MOD2 Funding Number: APS 442 13 000001 MOD2 Agency: Cambodia USAID Phnom Penh Category: Health Funding Amount: $100,000 |
| Human Heredity and Health in Africa (H3Africa) Ethical, Legal, and Societal Issues (ELSI) Research Program (U01) Apply for RFA RM 13 005 Funding Number: RFA RM 13 005 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (STTR)(R41/R42) Apply for PA 13 093 Funding Number: PA 13 093 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH13 1343", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.